With The Help Of e-Health Records, Colon Cancer Screening Doubles
3/05/2013
Researchers used electronic health records to identify Group Health patients who weren't screened regularly for cancer of the colon and rectum - and to encourage them to be screened. This centralized, automated approach doubled these patients' rates of on-time screening - and saved health costs - over two years. The March 5 Annals of Internal Medicine published the randomized controlled trial...
Treatment proven to demonstrate significant survival improvement in patients with mCRC whose disease has progressed despite treatment with oxaliplatin-based regimen2 Sanofi and Regeneron Pharmaceuticals, Inc...
A Tool That Could Simply And Accurately Determine The Right Dose For Oncology
3/05/2013
King Mithridates understood that poison is only as good as the dosage taken. Each day, he ingested small quantities of poison in order to become immune and escape his court's plotters. Oncologists run up against the same principle when fighting cancer. Sometimes, a small dose of chemotherapy may induce dangerous resistance mechanisms in malignant cells, resulting in relapse...
Common Cancer Vaccine Ingredient Diverts T Cells From Tumors
3/05/2013
Cancer vaccines that attempt to stimulate an immune system assault fail because the killer T cells aimed at tumors instead find the vaccination site a more inviting target, scientists at The University of Texas MD Anderson Cancer Center report in Nature Medicine...
Concerns Raised That The 'Shelf Life' Of Blood May Be Shorter Than We Think
3/05/2013
A small study from Johns Hopkins adds to the growing body of evidence that red blood cells stored longer than three weeks begin to lose the capacity to deliver oxygen-rich cells where they may be most needed...
Gene Related To Obesity Increases Risk For Melanoma
3/05/2013
The research shows that people with particular variations in a stretch of DNA within the FTO gene, called intron 8, could be at greater risk of developing melanoma. Variations in a different part of the FTO gene, called intron 1, are already known to be the most important genetic risk factor for obesity and overeating...
Research Offers Patients Hope For New Treatments For An Aggressive And Common Lymphoma
3/05/2013
The powerful master regulatory transcription factor called Bcl6 is key to the survival of a majority of aggressive lymphomas, which arise from the B-cells of the immune system. The protein has long been considered too complex to target with a drug since it is also crucial to the healthy functioning of many immune cells in the body, not just B cells gone bad...
News From The Annals Of Internal Medicine: March 5, 2013
3/05/2013
A special supplement on patient safety strategies will be published with the March 5 issue. In addition to the 10 articles included in the supplement, Annals of Internal Medicine also will publish a special five-page graphic narrative on the topic of medical errors. 1...
With The Help Of e-Health Records, Colon Cancer Screening Doubles
3/05/2013
Researchers used electronic health records to identify Group Health patients who weren't screened regularly for cancer of the colon and rectum - and to encourage them to be screened. This centralized, automated approach doubled these patients' rates of on-time screening - and saved health costs - over two years. The March 5 Annals of Internal Medicine published the randomized controlled trial...
Treatment proven to demonstrate significant survival improvement in patients with mCRC whose disease has progressed despite treatment with oxaliplatin-based regimen(2) Sanofi and Regeneron Pharmaceuticals, Inc...